» Articles » PMID: 26996992

Health Outcomes Among HIV-positive Latinos Initiating Antiretroviral Therapy in North America Versus Central and South America

Abstract

Introduction: Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of the care continuum, whereas in Latin America antiretroviral therapy (ART) services continue to expand to meet treatment needs. In this analysis, we compare HIV treatment outcomes between Latinos receiving ART in North America versus Latin America.

Methods: HIV-positive adults initiating ART at Caribbean, Central and South America Network for HIV (CCASAnet) sites were compared to Latino patients (based on country of origin or ethnic identity) starting treatment at North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) sites in the United States and Canada between 2000 and 2011. Cox proportional hazards models compared mortality, treatment interruption, antiretroviral regimen change, virologic failure and loss to follow-up between cohorts.

Results: The study included 8400 CCASAnet and 2786 NA-ACCORD patients initiating ART. CCASAnet patients were younger (median 35 vs. 37 years), more likely to be female (27% vs. 20%) and had lower nadir CD4 count (median 148 vs. 195 cells/µL, p<0.001 for all). In multivariable analyses, CCASAnet patients had a higher risk of mortality after ART initiation (adjusted hazard ratio (AHR) 1.61; 95% confidence interval (CI): 1.32 to 1.96), particularly during the first year, but a lower hazard of treatment interruption (AHR: 0.46; 95% CI: 0.42 to 0.50), change to second-line ART (AHR: 0.56; 95% CI: 0.51 to 0.62) and virologic failure (AHR: 0.52; 95% CI: 0.48 to 0.57).

Conclusions: HIV-positive Latinos initiating ART in Latin America have greater continuity of treatment but are at higher risk of death than Latinos in North America. Factors underlying these differences, such as HIV testing, linkage and access to care, warrant further investigation.

Citing Articles

The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.

Crabtree-Ramirez B, Belaunzaran-Zamudio P, Cortes C, Morales M, Sued O, Sierra-Madero J J Int AIDS Soc. 2020; 23(3):e25468.

PMID: 32115884 PMC: 7049674. DOI: 10.1002/jia2.25468.


Social and Structural Determinants of HIV Treatment and Care Among Hispanic Women and Latinas Living with HIV Infection in the United States: A Qualitative Review: 2008-2018.

Fugerson A, Sutton M, McCree D Health Equity. 2019; 3(1):581-587.

PMID: 31701083 PMC: 6830529. DOI: 10.1089/heq.2019.0039.


Trends and Disparities in Mortality and Progression to AIDS in the Highly Active Antiretroviral Therapy Era: Tennessee, 1996-2016.

Rebeiro P, Pettit A, Sizemore L, Mathieson S, Wester C, Kipp A Am J Public Health. 2019; 109(9):1266-1272.

PMID: 31318589 PMC: 6687251. DOI: 10.2105/AJPH.2019.305180.


Anal Cancer Prevention Perspectives Among Foreign-Born Latino HIV-Infected Gay and Bisexual Men.

Koskan A, Fernandez-Pineda M Cancer Control. 2018; 25(1):1073274818780368.

PMID: 29925247 PMC: 6028166. DOI: 10.1177/1073274818780368.


Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America.

Caro-Vega Y, Belaunzaran-Zamudio P, Crabtree-Ramirez B, Shepherd B, Grinsztejn B, Wolff M Open Forum Infect Dis. 2018; 5(3):ofy004.

PMID: 29527539 PMC: 5836274. DOI: 10.1093/ofid/ofy004.


References
1.
Torrone E, Thomas J, Leone P, Hightow-Weidman L . Late diagnosis of HIV in young men in North Carolina. Sex Transm Dis. 2007; 34(11):846-8. DOI: 10.1097/OLQ.0b013e31809505f7. View

2.
Castillo-Mancilla J, Allshouse A, Collins C, Hastings-Tolsma M, Campbell T, MaWhinney S . Differences in sexual risk behavior and HIV/AIDS risk factors among foreign-born and US-born Hispanic women. J Immigr Minor Health. 2011; 14(1):89-99. PMC: 4504232. DOI: 10.1007/s10903-011-9529-7. View

3.
Carriquiry G, Fink V, Koethe J, Giganti M, Jayathilake K, Blevins M . Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. J Int AIDS Soc. 2015; 18:20016. PMC: 4499577. DOI: 10.7448/IAS.18.1.20016. View

4.
Cesar C, Shepherd B, Krolewiecki A, Fink V, Schechter M, Tuboi S . Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One. 2010; 5(6):e10490. PMC: 2879360. DOI: 10.1371/journal.pone.0010490. View

5.
McGowan C, Cahn P, Gotuzzo E, Padgett D, Pape J, Wolff M . Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007; 36(5):969-76. DOI: 10.1093/ije/dym073. View